Aurobindo Pharma Ltd share price
Aurobindo Pharma Ltd (AUROPHARMA) is a stock listed on India's exchanges (NSE & BSE). It is commonly tracked under the Pharma theme. On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal — which star investors hold it and who is buying it on today's bulk/block deals tape.
Aurobindo Pharma Limited value chain — customers, suppliers & competitors
Aurobindo Pharma is a major Indian pharmaceutical company that manufactures and sells active pharmaceutical ingredients (APIs) and generic medicines globally to over 150 countries. It sits in the middle of the healthcare value chain, buying basic chemical raw materials and supplying finished drugs to global markets.
🛒 Customers — who buys from Aurobindo Pharma Limited
- Global institutional buyers and distributors — Generic pharmaceutical formulations and APIs
⛓️ Suppliers — raw materials & inputs
- Chemical and solvent suppliers — Key starting materials (KSMs) and basic chemical solvents
- Packaging material vendors — Bottles, foils, cartons, and blister packs
⚔️ Competitors — other sellers
- Lupin — Competes in global generic drug markets and US formulations, slightly smaller or comparable in US generic scale.
- Zydus Lifesciences — Competes directly across generic formulations, specialty products, and APIs.
- Alkem Laboratories — Competes in domestic and international branded and generic formulations.
🔀 Other suppliers to its customers
- Dr. Reddy's Laboratories — Supplies competing generic formulations and APIs to global customers.
- Sun Pharmaceutical Industries — A larger alternative supplier of generic drugs and finished dosages worldwide.
🤝 Peers that share its suppliers
- Divi's Laboratories — Shares similar raw material chemical ecosystems and API manufacturing inputs.
- Cipla — Buys similar bulk chemicals and intermediates for generic drug manufacturing.
This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.